In addition to the in vitro and in vivo assays, other analytic protocols used for CICs identification in lung cancer, including CD133 expression, ALDH activity, and chemoresistance assays, were used to verify the characteristics of the clones [7]. This evidence concerns the gene PROM1 and lung carcinoma.